ANIX Anixa Biosciences, Inc.
$3.03▲ +3.41%
Healthcare
Other
Volume 28.9K
Avg Volume (10D) 173.7K
Key Metrics & Fundamentals
Market Cap
$105.33M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.32 - 5.46
% vs 50 MA
-2.19%
% vs 200 MA
-1.26%
RSI-14
54.1
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.38
Free Cash Flow
-$1.77M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.73M
COGS
–
Operating Exp
$2.74M
Operating Income
-$2.74M
EBIT
-$2.74M
Pretax Income
-$2.63M
Net Income
-$2.61M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
PR Newswire · Oct 26, 2026 8:30 AM ET
Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
ACCESS Newswire · Oct 13, 2026 9:00 AM ET
Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
PR Newswire · Oct 13, 2026 8:40 AM ET
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
PR Newswire · Oct 5, 2026 8:15 AM ET
Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
PR Newswire · Oct 1, 2026 8:35 AM ET
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
PR Newswire · Sep 21, 2026 8:45 AM ET
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
PR Newswire · Sep 16, 2026 9:15 AM ET
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Sep 11, 2026 9:00 AM ET
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
PR Newswire · Sep 9, 2026 8:35 AM ET
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
PR Newswire · Sep 3, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ANIX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.